Tesamorelin therapy reduces visceral adipose tissue in HIV lipodystrophy
New England Journal of Medicine
2010
Study summary
Tesamorelin was studied in patients with HIV-associated lipodystrophy.
Peptides studied
Stack studied
GH Optimization Stack
Key findings
Significant reduction in visceral adipose tissue and increase in IGF-1 levels observed.
Study details
Study type
randomized clinical trial
Journal
New England Journal of Medicine
DOI / PubMed
10.1056/NEJMoa0911289
Year
2010
Explore peptide profiles
Discover compounds, understand their mechanisms, and explore the research behind each peptide.
